BC Week In Review | Jul 5, 2010
Company News

Jiangxi Aiqilin Pharmaceuticals, Uluru deal

Uluru granted Jiangxi rights to commercialize Altrazeal in China, Hong Kong, Macau and Taiwan. Uluru already markets the antimicrobial dressing incorporating the company's Nanoflex nanoparticle aggregate technology in the U.S. for wound management. Uluru said...
BC Week In Review | Oct 27, 2008
Clinical News

Altrazeal Silver: Pivotal trial started

Uluru began a U.S. pivotal trial to compare Altrazeal Silver vs. a marketed silver-containing carboxymethylcellulose dressing in 40 patients undergoing skin grafts. Uluru Inc. (OTCBB:ULUR), Addison, Texas   Product: Altrazeal Silver   Business: Dermatology  ...
BC Week In Review | Oct 6, 2008
Clinical News

Altrazeal Silver regulatory update

Uluru submitted a 510(k) application to FDA for its Altrazeal Silver to treat wounds. Uluru plans to launch the silver-containing antimicrobial dressing, which incorporates the company's Nanoflex nanoparticle aggregate technology, in 1Q09. Uluru Inc. (OTCBB:ULUR),...
Items per page:
1 - 3 of 3